Replies to post #320934 on Avid Bioservices Inc (CDMO)

[north40000]

You must realize your remark(the sarcasm is evident, IMO) is misplaced if not irrelevant. Having finished its pre-clinical work, MSKCC appears to be now ready to place its therapy into clinical trials in humans.